Drugmaker Shire Wins Baxalta for $32 Billion After Six-Month Pursuit

January 11, 2016

Note: The following story was published by Reuters聽on Monday, January 11, 2016 . It can be found here. Drugmaker Shire Plc clinched its six-month pursuit of Baxalta International Inc on Monday with an agreed $32 billion cash and stock offer, catapulting it to a leading position in treating rare diseases. The London-listed group, which first […]

Sign up for E-mails, Dateline Magazine, and other ways to stay connected.